D20054;LITT for Spine Tumors

Last updated: April 1, 2025
Sponsor: Dartmouth-Hitchcock Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neoplasm Metastasis

Treatment

Visualase Thermal Therapy System

Clinical Study ID

NCT06548061
STUDY02001761
  • Ages > 18
  • All Genders

Study Summary

The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Histology confirmed spinal tumor involving the T2-T12 spine segments.

  2. Indication for spine stereotactic radiosurgery or palliative intervention.

  3. Normal neurologic exam at the time of presentation (Frankel grade E).

Exclusion

Exclusion Criteria:

  1. Contraindication to MRI

  2. ANY neurologic deficit

  3. Tumor spanning more than 3 consecutive vertebral segments

  4. Contraindication to general anesthesia

  5. Pregnancy

Study Design

Total Participants: 25
Treatment Group(s): 1
Primary Treatment: Visualase Thermal Therapy System
Phase:
Study Start date:
May 16, 2024
Estimated Completion Date:
June 01, 2029

Connect with a study center

  • Dartmouth Health

    Lebanon, New Hampshire 03766
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.